Dr. Brennan is Partner at Merck MRL Ventures Fund. She has over 15 years experience within the biotech, venture and large pharma segments of the biopharmaceutical industry, accumulating a broad range of experiences identifying and matching high-quality science with strategic need. Prior to joining MRL Ventures Fund, Dr. Brennan served as Principal of Novartis Ventur Funds and Chief Business Officer of Vitae Pharmaceuticals. Before Vitae she was Executive Director and Head of Strategy and Operations for Strategic Alliances at Novartis’ Institutes for BioMedical Research. Prior to Novartis, she worked at Fidelity Biosciences, a private equity venture capital company, and prior to that Dr. Brennan worked in business development for several early-stage biotechnology companies. She holds a Ph.D. in neuroscience from Dartmouth Medical School and a B.S. in biochemistry from the University of New Hampshire.